223 related articles for article (PubMed ID: 33706339)
1. Medication Abortion With Pharmacist Dispensing of Mifepristone.
Grossman D; Baba CF; Kaller S; Biggs MA; Raifman S; Gurazada T; Rafie S; Averbach S; Meckstroth KR; Micks EA; Berry E; Raine-Bennett TR; Creinin MD
Obstet Gynecol; 2021 Apr; 137(4):613-622. PubMed ID: 33706339
[TBL] [Abstract][Full Text] [Related]
2. Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment.
Grossman D; Raifman S; Morris N; Arena A; Bachrach L; Beaman J; Biggs MA; Hannum C; Ho S; Schwarz EB; Gold M
Contraception; 2022 Mar; 107():36-41. PubMed ID: 34555420
[TBL] [Abstract][Full Text] [Related]
3. Mail-Order Pharmacy Dispensing of Mifepristone for Medication Abortion After In-Person Screening.
Grossman D; Raifman S; Morris N; Arena A; Bachrach L; Beaman J; Biggs MA; Collins A; Hannum C; Ho S; Seibold-Simpson SM; Sobota M; Tocce K; Schwarz EB; Gold M
JAMA Intern Med; 2024 May; ():. PubMed ID: 38739404
[TBL] [Abstract][Full Text] [Related]
4. Pharmacist provision of medication abortion: A pilot study.
Sandoval S; Rafie S; Kully G; Mody S; Averbach S
Contraception; 2024 Mar; 131():110346. PubMed ID: 38065286
[TBL] [Abstract][Full Text] [Related]
5. Pharmacists' knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion.
Kaller S; Morris N; Biggs MA; Baba CF; Rafie S; Raine-Bennett TR; Creinin MD; Berry E; Micks EA; Meckstroth KR; Averbach S; Grossman D
J Am Pharm Assoc (2003); 2021; 61(6):785-794.e1. PubMed ID: 34281806
[TBL] [Abstract][Full Text] [Related]
6. Client satisfaction and experience of telemedicine and home use of mifepristone and misoprostol for abortion up to 10 weeks' gestation at British Pregnancy Advisory Service: A cross-sectional evaluation.
Meurice ME; Whitehouse KC; Blaylock R; Chang JJ; Lohr PA
Contraception; 2021 Jul; 104(1):61-66. PubMed ID: 33974918
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of early medication abortion provided in pharmacies by auxiliary nurse-midwives: A non-inferiority study in Nepal.
Rocca CH; Puri M; Shrestha P; Blum M; Maharjan D; Grossman D; Regmi K; Darney PD; Harper CC
PLoS One; 2018; 13(1):e0191174. PubMed ID: 29351313
[TBL] [Abstract][Full Text] [Related]
8. Introducing medication abortion into public sector facilities in KwaZulu-Natal, South Africa: an operations research study.
Blanchard K; Lince-Deroche N; Fetters T; Devjee J; de Menezes ID; Trueman K; Sudhinaraset M; Nkonko E; Moodley J
Contraception; 2015 Oct; 92(4):330-8. PubMed ID: 26162575
[TBL] [Abstract][Full Text] [Related]
9. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
[TBL] [Abstract][Full Text] [Related]
10. Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic.
Chong E; Shochet T; Raymond E; Platais I; Anger HA; Raidoo S; Soon R; Grant MS; Haskell S; Tocce K; Baldwin MK; Boraas CM; Bednarek PH; Banks J; Coplon L; Thompson F; Priegue E; Winikoff B
Contraception; 2021 Jul; 104(1):43-48. PubMed ID: 33781762
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of a hospital outpatient day procedure for medication abortion at 13-18 weeks gestation: Findings from Nepal
Blum J; Karki C; Tamang A; Shochet T; Shrestha A; Tuladhar H; Karki A; Sharma J; Abbas DF; Dragoman M; Winikoff B
Contraception; 2019 Dec; 100(6):451-456. PubMed ID: 31491379
[TBL] [Abstract][Full Text] [Related]
12. Pharmacists' experiences dispensing misoprostol and readiness to dispense mifepristone.
Ferketa M; Moore A; Klein-Barton J; Stulberg D; Hasselbacher L
J Am Pharm Assoc (2003); 2024; 64(1):245-252.e1. PubMed ID: 37913990
[TBL] [Abstract][Full Text] [Related]
13. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.
Schaff EA; Fielding SL; Eisinger SH; Stadalius LS; Fuller L
Contraception; 2000 Jan; 61(1):41-6. PubMed ID: 10745068
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
Gatter M; Cleland K; Nucatola DL
Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
[TBL] [Abstract][Full Text] [Related]
15. Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States.
Koenig LR; Raymond EG; Gold M; Boraas CM; Kaneshiro B; Winikoff B; Coplon L; Upadhyay UD
Contraception; 2023 May; 121():109962. PubMed ID: 36736715
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of self-managed medication abortion with accompaniment support in Argentina and Nigeria (SAFE): a prospective, observational cohort study and non-inferiority analysis with historical controls.
Moseson H; Jayaweera R; Egwuatu I; Grosso B; Kristianingrum IA; Nmezi S; Zurbriggen R; Motana R; Bercu C; Carbone S; Gerdts C
Lancet Glob Health; 2022 Jan; 10(1):e105-e113. PubMed ID: 34801131
[TBL] [Abstract][Full Text] [Related]
17. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
[TBL] [Abstract][Full Text] [Related]
18. Extending outpatient medical abortion services through 70 days of gestational age.
Winikoff B; Dzuba IG; Chong E; Goldberg AB; Lichtenberg ES; Ball C; Dean G; Sacks D; Crowden WA; Swica Y
Obstet Gynecol; 2012 Nov; 120(5):1070-6. PubMed ID: 23090524
[TBL] [Abstract][Full Text] [Related]
19. Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models.
Kerestes C; Murayama S; Tyson J; Natavio M; Seamon E; Raidoo S; Lacar L; Bowen E; Soon R; Platais I; Kaneshiro B; Stowers P
Contraception; 2021 Jul; 104(1):49-53. PubMed ID: 33789080
[TBL] [Abstract][Full Text] [Related]
20. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.
Schaff EA; Fielding SL; Westhoff C; Ellertson C; Eisinger SH; Stadalius LS; Fuller L
JAMA; 2000 Oct; 284(15):1948-53. PubMed ID: 11035891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
